Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia-Reference-Cited by-同舟云学术

Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia

Published:2020-12-25 Issue:1 Volume:26 Page:31-36
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Chen Mo¹,Fang Jian-Pei²,Zhou Chuan-Xin¹,Li Xin-Yu²^ORCID,Lin Shao-Fen²,Xu Lu-Hong²^ORCID

Affiliation:

1. Guangdong Provincial Key Laboratory of Biomedical Imaging, Department of Pediatrics, Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, People’s Republic of China

2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Pediatrics, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People’s Republic of China

Funder

Natural Science Foundation of Guangdong Province

Guangdong Basic and Applied Basic Research Foundation

Zhuhai Technology Plan Program of Medicine and Health

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2020.1856511

Reference28 articles.

1. Pediatric ITP: is it different from adult ITP?

2. Controversias en el tratamiento de la trombocitopenia inmune pediátrica

4. Diagnosis and management of immune thrombocytopenia in childhood

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eltrombopag Use in Children with Persistent and Chronic Primary Immune Thrombocytopenia in a Portuguese Pediatric Center;Acta Médica Portuguesa;2024-04-01

2. Long term use of eltrombopag in children with chronic immune thrombocytopenia: extended real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology;Frontiers in Medicine;2023-07-14

3. Evaluation of the effect of eltrombopag therapy on the platelet collagen receptor glycoprotein VI (GPVI) expression and soluble GPVI levels in young patients with immune thrombocytopenia;Journal of Thrombosis and Thrombolysis;2022-12-07

4. Eltrombopag-induced liver dysfunction during the treatment of immune thrombocytopenia and its risk factors;Annals of Palliative Medicine;2021-06